Second-opinion imaging readings can directly affect the clinical management of patients with Hepatopancreaticobiliary (HPB) disease, reported authors of a Sept. 24 study in the American Journal of Roentgenology.

SCAN Health Plan, a leading senior-focused organization with the mission of keeping seniors healthy and independent, today announced Adrienne Morrell as its senior vice president of public, government and community affairs.

Intelerad Medical Systems™, a leader in enterprise workflow solutions, is pleased to announce that following the retirement of Randall Oka, its board of directors has appointed Paul Lepage as its new president and chief executive officer.

A cancer center’s fundraising campaign will no longer focus on the use of artificial intelligence (AI) in cancer treatments following accusations it commercialized the work of employees for private gain, according to a report by The New York Times and ProPublica.

CHS, one of the nation’s largest publicly traded hospital companies and operators, has settled with the U.S. Department of Justice for $262 million over an investigation of kickback and false billing allegations related to a hospital company it acquired in 2014.

Health insurance giant Humana is teaming up with the University of Houston in a long-term strategic partnership focused on training healthcare professionals on population health and value-based care.

The Massachusetts Office of the Attorney General announced on Thursday, Sept. 20, that UMass Memorial Medical Group, Inc. and UMass Memorial Medical Center, Inc. have been ordered to pay $230,000 following two separate data breaches that exposed the personal health information of more than 15,000 people.

Intravascular ultrasound (IVUS)-guided stent implantation offers improved clinical outcomes for heart patients over a traditional angiography-guided approach, researchers from China reported at this week’s Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Diego, California.

Alzheimer’s could be diagnosed earlier if the blood-brain barrier was monitored as a biomarker and potential drug target using MRI or PET, according to research published online Sept. 24 in Nature Neuroscience.

The ongoing trade war between the United States and China, one of 2018’s biggest economic storylines, has continued to be a hot topic among healthcare providers and vendors.